- Home
- MRK vs JLS Comparison
MRK vs JLS Comparison
Compare MRK & JLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRK
- JLS
- Stock Information
- Founded
- MRK 2000
- JLS 2009
- Country
- MRK United States
- JLS United States
- Employees
- MRK N/A
- JLS N/A
- Industry
- MRK Biotechnology: Pharmaceutical Preparations
- JLS Investment Managers
- Sector
- MRK Health Care
- JLS Finance
- Exchange
- MRK Nasdaq
- JLS Nasdaq
- Market Cap
- MRK 198.5B
- JLS 97.1M
- IPO Year
- MRK N/A
- JLS N/A
- Fundamental
- Price
- MRK $83.70
- JLS $19.02
- Analyst Decision
- MRK Buy
- JLS
- Analyst Count
- MRK 15
- JLS 0
- Target Price
- MRK $113.14
- JLS N/A
- AVG Volume (30 Days)
- MRK 18.2M
- JLS 26.6K
- Earning Date
- MRK 07-29-2025
- JLS 01-01-0001
- Dividend Yield
- MRK 3.89%
- JLS 9.33%
- EPS Growth
- MRK 667.14
- JLS N/A
- EPS
- MRK 6.88
- JLS N/A
- Revenue
- MRK $63,922,000,000.00
- JLS N/A
- Revenue This Year
- MRK $2.42
- JLS N/A
- Revenue Next Year
- MRK $5.77
- JLS N/A
- P/E Ratio
- MRK $12.12
- JLS N/A
- Revenue Growth
- MRK 4.10
- JLS N/A
- 52 Week Low
- MRK $73.31
- JLS $15.48
- 52 Week High
- MRK $129.93
- JLS $17.97
- Technical
- Relative Strength Index (RSI)
- MRK 61.93
- JLS 78.44
- Support Level
- MRK $82.26
- JLS $18.94
- Resistance Level
- MRK $85.00
- JLS $18.95
- Average True Range (ATR)
- MRK 1.84
- JLS 0.16
- MACD
- MRK 0.36
- JLS 0.03
- Stochastic Oscillator
- MRK 81.05
- JLS 96.00
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
About JLS Nuveen Mortgage and Income Fund
Nuveen Mortgage And Income Fund is a diversified, closed-end management investment company. The fund invests at least fifty percent of its Managed Assets in MBS, including residential MBS and commercial MBS, and up to fifty percent in non-mortgage related ABS. Its investment objective to generate high current income through opportunistic investments in securitized credit.